IN2014MN02275A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN02275A IN2014MN02275A IN2275MUN2014A IN2014MN02275A IN 2014MN02275 A IN2014MN02275 A IN 2014MN02275A IN 2275MUN2014 A IN2275MUN2014 A IN 2275MUN2014A IN 2014MN02275 A IN2014MN02275 A IN 2014MN02275A
- Authority
- IN
- India
- Prior art keywords
- plasmodium
- against malaria
- host
- vertebrate
- rodent plasmodium
- Prior art date
Links
- 241000224016 Plasmodium Species 0.000 abstract 4
- 241000283984 Rodentia Species 0.000 abstract 3
- -1 ganism Species 0.000 abstract 3
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 2
- 201000004792 malaria Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000001524 infective effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT10626212 | 2012-04-17 | ||
| PCT/IB2013/053050 WO2013156949A1 (en) | 2012-04-17 | 2013-04-17 | Rodent plasmodium parasites as platforms for a whole-organism malaria vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN02275A true IN2014MN02275A (OSRAM) | 2015-08-07 |
Family
ID=48539330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2275MUN2014 IN2014MN02275A (OSRAM) | 2012-04-17 | 2013-04-17 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9655957B2 (OSRAM) |
| EP (1) | EP2838554B1 (OSRAM) |
| JP (1) | JP6096884B2 (OSRAM) |
| CN (1) | CN104302313B (OSRAM) |
| AU (1) | AU2013250814B2 (OSRAM) |
| BR (1) | BR112014025823A8 (OSRAM) |
| IN (1) | IN2014MN02275A (OSRAM) |
| PT (1) | PT2838554T (OSRAM) |
| WO (1) | WO2013156949A1 (OSRAM) |
| ZA (1) | ZA201408440B (OSRAM) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104771752B (zh) * | 2015-04-21 | 2018-01-05 | 中国人民解放军第三军医大学 | 疟疾红内期灭活全虫疫苗的新用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004309380B2 (en) * | 2003-12-19 | 2010-04-29 | Seattle Biomedical Research Institute | Live genetically attenuated malaria vaccine |
| US7722860B2 (en) * | 2004-12-03 | 2010-05-25 | Seattle Biomedical Research Institute | Live genetically engineered protozoan vaccine |
| FR2978048B1 (fr) * | 2011-07-20 | 2014-10-10 | Univ Paris Curie | Composition vaccinale contre le paludisme |
-
2013
- 2013-04-17 BR BR112014025823A patent/BR112014025823A8/pt not_active IP Right Cessation
- 2013-04-17 AU AU2013250814A patent/AU2013250814B2/en not_active Expired - Fee Related
- 2013-04-17 CN CN201380020546.7A patent/CN104302313B/zh not_active Expired - Fee Related
- 2013-04-17 JP JP2015506341A patent/JP6096884B2/ja not_active Expired - Fee Related
- 2013-04-17 WO PCT/IB2013/053050 patent/WO2013156949A1/en not_active Ceased
- 2013-04-17 US US14/394,964 patent/US9655957B2/en active Active
- 2013-04-17 PT PT13726295T patent/PT2838554T/pt unknown
- 2013-04-17 EP EP13726295.2A patent/EP2838554B1/en not_active Not-in-force
- 2013-04-17 IN IN2275MUN2014 patent/IN2014MN02275A/en unknown
-
2014
- 2014-11-17 ZA ZA2014/08440A patent/ZA201408440B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN104302313B (zh) | 2018-01-26 |
| EP2838554B1 (en) | 2018-08-22 |
| US20150071966A1 (en) | 2015-03-12 |
| US9655957B2 (en) | 2017-05-23 |
| CN104302313A (zh) | 2015-01-21 |
| JP6096884B2 (ja) | 2017-03-15 |
| BR112014025823A2 (OSRAM) | 2017-06-20 |
| AU2013250814A1 (en) | 2014-12-04 |
| HK1206243A1 (en) | 2016-01-08 |
| ZA201408440B (en) | 2015-12-23 |
| BR112014025823A8 (pt) | 2017-07-25 |
| JP2015514745A (ja) | 2015-05-21 |
| EP2838554A1 (en) | 2015-02-25 |
| AU2013250814B2 (en) | 2017-03-02 |
| WO2013156949A1 (en) | 2013-10-24 |
| PT2838554T (pt) | 2018-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018501515A1 (en) | Parenteral novovirus vaccine formulations | |
| PH12017500727A1 (en) | Modified virus-like particles of cmv | |
| MX352324B (es) | Vacunas multivalentes de nanovehiculos sinteticos. | |
| PH12013502442A1 (en) | Inactivated dengue virus vaccine | |
| SG10201903349YA (en) | Recombinant listeria vaccine strains and methods of using the same in cancer immunotherapy | |
| EA201290876A1 (ru) | Композиции индуцированных дендритных клеток и их использование | |
| MY168959A (en) | Vaccine compositions for the prevention of dengue virus infection | |
| PH12014502875A1 (en) | Vaccine compositions for prevention against dengue virus infection | |
| EP2679683A4 (en) | NEW VARICELLA ZOSTER VIRUSES AND WINDPOCK AND HERPES ZOSTER VIRUS VACCINE THEREOF | |
| PH12017500304A1 (en) | Vaccine compositions against dengue virus diseases | |
| NZ715459A (en) | A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same | |
| IN2015KN00516A (OSRAM) | ||
| MD20120127A2 (en) | Recombinant Koi herpesvirus (KHV), method for its production and vaccine for the prevention of a disease caused by KHV | |
| MA37749A1 (fr) | Vaccins contre les virus réassortis de la fièvre catarrhale et de la peste équine | |
| EA033027B1 (ru) | Ослабленные вакцины от свиного гриппа и способы их получения и применения | |
| IN2014MN02275A (OSRAM) | ||
| GB201112587D0 (en) | Vaccine | |
| EP2785369A4 (en) | IMMUNOGENIC PLASMODIUM FALCIPARUM ANTIGEN COMPOSITIONS AND USES THEREOF | |
| WO2012134591A3 (en) | Plasmodium falciparum antigens | |
| BRPI0924581A2 (pt) | seqüências geneticamente modificadas de antígenos de plasmodium vivax, composições vacinais contendo proteínas recombinantes e vírus recombinantes que expressam esses antígenos e método de vacinação dose-reforço contra malária | |
| UA106111C2 (uk) | Спосіб отримання людського інтерферону з використанням наночастинок оксиду церію | |
| BR112016025199A8 (pt) | métodos de cultura de esporozoítos de plasmodium infecciosos in vitro e para aumentar a produção de oocistos de plasmodium, bem como a referida cultura |